Biomaterials and Biosystems
Findings from a proof-of-concept, expanded access trial for COVID-19 patients prove the acellular biologic is safe and potentiallyective to prevent disease progression in a high-risk COVID-19 population with mild-to-moderate symptoms.
M. Bellio, Cassie Bennett, A. Arango et al.
· 0 citations